Article

SARS-CoV-2 B.1.617 emergence and sensitivity to vaccine-elicited antibodies

2021-05-09

Abstract excerpt

The SARS-CoV-2 B.1.617.2 (Delta) variant was first identified in the state of Maharashtra in late 2020 and spread throughout India, displacing the B.1.1.7 (Alpha) variant and other pre-existing lineages, including B.1.617.1 that was detected prior to B.1.617.2. Bayesian modelling indicates that the growth advantage of B.1.617.2 in Mumbai was most likely explained by increased transmissibility and immune evasion fr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b9c10505-c5d3-5ffd-bd3d-bdd34b553121
DOI: 10.60692/dy28a-h7650

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

SARS-CoV-2 B.1.617 emergence and sensitivity to vaccine-elicited antibodiesDOI 10.60692/dy28a-h7650Read

SARS-CoV-2 B.1.617.2 Delta variant replication, sensitivity to neutralising antibodies and vaccine breakthroughSemantic proximity Read

Reduced sensitivity of infectious SARS-CoV-2 variant B.1.617.2 to monoclonal antibodies and sera from convalescent and vaccinated individualsSemantic proximity Read

SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasionSemantic proximity Read

SARS-CoV-2 B.1.617.2 Delta variant emergence and vaccine breakthroughSemantic proximity Read

Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccinationSemantic proximity Read

Increased lung cell entry of B.1.617.2 and evasion of antibodies induced by infection and BNT162b2 vaccinationSemantic proximity Read

SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccinationSemantic proximity Read

Comparable neutralization of SARS-CoV-2 Delta AY.1 and Delta in individuals sera vaccinated with BBV152Semantic proximity Read

SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion.Semantic proximity Read

Impact of B.1.617 and RBD SARS-CoV-2 Variants on Vaccine Efficacy: An In-silico ApproachSemantic proximity Read

SARS-CoV-2 Mutations Responsible for Immune Evasion Leading to Breakthrough InfectionSemantic proximity Read

Neutralization of Delta variant with sera of Covishield vaccinees and COVID-19 recovered vaccinated individualsSemantic proximity Read